GE HealthCare Technologies (NASDAQ:GEHC) Insider Frank Jimenez Buys 1,750 Shares

GE HealthCare Technologies Inc. (NASDAQ:GEHC) insider Frank Jimenez purchased 1,750 shares of the stock in a transaction on Thursday, April 30th. The shares were purchased at an average price of $60.45 per share, for a total transaction of $105,787.50. Following the transaction, the insider directly owned 93,932 shares of the company’s stock, valued at approximately $5,678,189.40. This represents a 1.90% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this link.

GE HealthCare Technologies Trading Up 2.3%

NASDAQ GEHC opened at $60.84 on Friday. The stock’s 50-day simple moving average is $73.28 and its two-hundred day simple moving average is $77.52. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a quick ratio of 1.13, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The company has a market capitalization of $27.76 billion, a price-to-earnings ratio of 14.56, a PEG ratio of 1.34 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The firm had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.9 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be issued a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 3.35%.

GE HealthCare Technologies News Summary

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Insiders bought shares — CEO Peter Arduini purchased 4,169 shares (~$59.92 avg) and director Frank R. Jimenez bought 1,750 shares; insider buys are often read as management confidence and can support the stock. SEC Form 4: Arduini
• Neutral Sentiment: Operational restructure — GEHC is combining Imaging and Advanced Visualization into a new Advanced Imaging Solutions unit and announced executive changes to improve execution; strategic but benefits may be multi‑quarter. BusinessWire: Operational Updates
• Neutral Sentiment: Wells Fargo set a new $75 price target (down from $97) but kept an overweight rating — implies upside vs. current levels but signals tempered near‑term expectations. AmericanBankingNews: Wells Fargo PT
• Negative Sentiment: Guidance cut and margin pressure — management trimmed FY26 EPS to $4.80–5.00, citing inflation, higher chip/oil/freight costs and supply‑chain pressures; this is the primary driver of the recent sell‑off. Reuters: Guidance Cut
• Negative Sentiment: Q1 was mixed but weak on profits — revenue beat (~$5.13B) but EPS missed ($0.99 vs $1.07 est.) and margins compressed, reinforcing short‑term downside risk. Zacks: Q1 Results
• Negative Sentiment: Analyst downgrades/price‑target cuts — Citigroup and JPMorgan trimmed targets to $65 (neutral), and other firms adjusted targets/ratings, signaling reduced near‑term expectations from sell‑side desks. AmericanBankingNews: Citigroup PT Cut
• Negative Sentiment: Investor litigation inquiry — Johnson Fistel is investigating potential claims relating to executives, adding legal/regulatory risk and headline volatility. GlobeNewswire: Litigation Notice

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Citigroup decreased their price objective on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday. Bank of America boosted their price target on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a report on Monday, January 5th. JPMorgan Chase & Co. reduced their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday. Piper Sandler reduced their price target on GE HealthCare Technologies from $96.00 to $88.00 and set an “overweight” rating on the stock in a report on Friday, April 17th. Finally, The Goldman Sachs Group downgraded GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price target for the company from $81.00 to $65.00 in a report on Thursday. Eight equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Hold” and an average target price of $80.67.

Institutional Trading of GE HealthCare Technologies

Several large investors have recently bought and sold shares of GEHC. Empowered Funds LLC boosted its position in GE HealthCare Technologies by 6.1% during the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock valued at $2,328,000 after acquiring an additional 1,665 shares in the last quarter. Acadian Asset Management LLC bought a new stake in GE HealthCare Technologies during the 1st quarter valued at approximately $259,000. Cresset Asset Management LLC boosted its position in GE HealthCare Technologies by 12.5% during the 2nd quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock valued at $578,000 after acquiring an additional 865 shares in the last quarter. Jump Financial LLC boosted its position in GE HealthCare Technologies by 317.6% during the 2nd quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock valued at $2,084,000 after acquiring an additional 21,396 shares in the last quarter. Finally, Gamco Investors INC. ET AL boosted its position in GE HealthCare Technologies by 8.6% during the 2nd quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock valued at $299,000 after acquiring an additional 320 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.